These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
451 related articles for article (PubMed ID: 2560985)
1. The dexamethasone suppression test and long-term contraceptive treatment: measurement of ACTH or salivary cortisol does not improve the reliability of the test. Nickelsen T; Lissner W; Schöffling K Exp Clin Endocrinol; 1989; 94(3):275-80. PubMed ID: 2560985 [TBL] [Abstract][Full Text] [Related]
2. A dose-response study of salivary cortisol after dexamethasone suppression test in Cushing's disease and its potential use in the differential diagnosis of Cushing's syndrome. Castro M; Elias LL; Elias PC; Moreira AC Clin Endocrinol (Oxf); 2003 Dec; 59(6):800-5. PubMed ID: 14974925 [TBL] [Abstract][Full Text] [Related]
3. Low-dose ACTH (1 microg) salivary test: a potential alternative to the classical blood test. Marcus-Perlman Y; Tordjman K; Greenman Y; Limor R; Shenkerman G; Osher E; Stern N Clin Endocrinol (Oxf); 2006 Feb; 64(2):215-8. PubMed ID: 16430723 [TBL] [Abstract][Full Text] [Related]
4. Salivary cortisol determined by enzyme immunoassay is preferable to serum total cortisol for assessment of dynamic hypothalamic--pituitary--adrenal axis activity. Gozansky WS; Lynn JS; Laudenslager ML; Kohrt WM Clin Endocrinol (Oxf); 2005 Sep; 63(3):336-41. PubMed ID: 16117823 [TBL] [Abstract][Full Text] [Related]
5. Plasma and salivary 6beta-hydroxycortisol measurements for assessing adrenocortical activity in patients with adrenocortical adenomas. Varga I; Jakab C; Szücs N; Patócs A; Tóth M; Kiss R; Gláz E; Rácz K Horm Metab Res; 2003 Jul; 35(7):421-6. PubMed ID: 12931273 [TBL] [Abstract][Full Text] [Related]
6. Long-term remission rates after pituitary surgery for Cushing's disease: the need for long-term surveillance. Atkinson AB; Kennedy A; Wiggam MI; McCance DR; Sheridan B Clin Endocrinol (Oxf); 2005 Nov; 63(5):549-59. PubMed ID: 16268808 [TBL] [Abstract][Full Text] [Related]
7. The influence of the route of oestrogen administration on serum levels of cortisol-binding globulin and total cortisol. Qureshi AC; Bahri A; Breen LA; Barnes SC; Powrie JK; Thomas SM; Carroll PV Clin Endocrinol (Oxf); 2007 May; 66(5):632-5. PubMed ID: 17492949 [TBL] [Abstract][Full Text] [Related]
8. Pituitary function and DHEA-S in male acne and DHEA-S, prolactin and cortisol before and after oral contraceptive treatment in female acne. Palatsi R; Reinilä M; Kivinén S Acta Derm Venereol; 1986; 66(3):225-30. PubMed ID: 2426899 [TBL] [Abstract][Full Text] [Related]
9. Changes in haemostatic variables induced by oral contraceptives containing 50 micrograms or 30 micrograms oestrogen: absence of dose-dependent effect on PAI-1 activity. Scarabin PY; Plu-Bureau G; Zitoun D; Bara L; Guize L; Samama MM Thromb Haemost; 1995 Sep; 74(3):928-32. PubMed ID: 8571323 [TBL] [Abstract][Full Text] [Related]
10. Transitory hypoadrenalism due to long-term treatment with antiovulatory compounds. Leiba S; Kaufman H; Winkelsberg G; Bahary C Isr J Med Sci; 1979 May; 15(5):434-7. PubMed ID: 221439 [TBL] [Abstract][Full Text] [Related]
12. Assessment of serum-free cortisol levels in patients with adrenocortical carcinoma treated with mitotane: a pilot study. Alexandraki KI; Kaltsas GA; le Roux CW; Fassnacht M; Ajodha S; Christ-Crain M; Akker SA; Drake WM; Edwards R; Allolio B; Grossman AB Clin Endocrinol (Oxf); 2010 Mar; 72(3):305-11. PubMed ID: 19473175 [TBL] [Abstract][Full Text] [Related]
13. A comparison of the standard high dose dexamethasone suppression test and the overnight 8-mg dexamethasone suppression test for the differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome. Dichek HL; Nieman LK; Oldfield EH; Pass HI; Malley JD; Cutler GB J Clin Endocrinol Metab; 1994 Feb; 78(2):418-22. PubMed ID: 8106630 [TBL] [Abstract][Full Text] [Related]
14. Six-month oral dehydroepiandrosterone supplementation in early and late postmenopause. Stomati M; Monteleone P; Casarosa E; Quirici B; Puccetti S; Bernardi F; Genazzani AD; Rovati L; Luisi M; Genazzani AR Gynecol Endocrinol; 2000 Oct; 14(5):342-63. PubMed ID: 11109974 [TBL] [Abstract][Full Text] [Related]
15. Adrenal function under long-term raloxifene administration. Genazzani AR; Lombardi I; Borgioli G; di Bono I; Casarosa E; Gambacciani M; Palumbo M; Genazzani AD; Luisi M Gynecol Endocrinol; 2003 Apr; 17(2):159-68. PubMed ID: 12737677 [TBL] [Abstract][Full Text] [Related]
16. Cortisol and ACTH responses to psychosocial stress are modulated by corticosteroid binding globulin levels. Kumsta R; Entringer S; Hellhammer DH; Wüst S Psychoneuroendocrinology; 2007; 32(8-10):1153-7. PubMed ID: 17904296 [TBL] [Abstract][Full Text] [Related]
17. Advantage of salivary cortisol measurements in the diagnosis of glucocorticoid related disorders. Restituto P; Galofré JC; Gil MJ; Mugueta C; Santos S; Monreal JI; Varo N Clin Biochem; 2008 Jun; 41(9):688-92. PubMed ID: 18280810 [TBL] [Abstract][Full Text] [Related]
18. Cortisol and ACTH response to oral dexamethasone in obesity and effects of sex, body fat distribution, and dexamethasone concentrations: a dose-response study. Pasquali R; Ambrosi B; Armanini D; Cavagnini F; Uberti ED; Del Rio G; de Pergola G; Maccario M; Mantero F; Marugo M; Rotella CM; Vettor R; J Clin Endocrinol Metab; 2002 Jan; 87(1):166-75. PubMed ID: 11788642 [TBL] [Abstract][Full Text] [Related]
19. Massive weight loss decreases corticosteroid-binding globulin levels and increases free cortisol in healthy obese patients: an adaptive phenomenon? Manco M; Fernández-Real JM; Valera-Mora ME; Déchaud H; Nanni G; Tondolo V; Calvani M; Castagneto M; Pugeat M; Mingrone G Diabetes Care; 2007 Jun; 30(6):1494-500. PubMed ID: 17526821 [TBL] [Abstract][Full Text] [Related]
20. Technical note: comparison of salivary and serum cortisol concentrations after adrenocorticotropic hormone challenge in ewes. Yates DT; Ross TT; Hallford DM; Yates LJ; Wesley RL J Anim Sci; 2010 Feb; 88(2):599-603. PubMed ID: 19854993 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]